Evidence map›Paper›PMID 28118367›Full record

ArticlePLoS neglected tropical diseases2017

Characterizing Antibody Responses to Plasmodium vivax and Plasmodium falciparum Antigens in India Using Genome-Scale Protein Microarrays.

Swapna Uplekar, Pavitra Nagesh Rao, Lalitha Ramanathapuram, Vikky Awasthi, Kalpana Verma, Patrick Sutton, Syed Zeeshan Ali, Ankita Patel, Sri Lakshmi Priya G, Sangamithra Ravishankaran and 13 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Sterile protection againstLife science alliance · 2024
    Article
  2. Article
  3. Review
  4. Naturally acquired antibody response toFrontiers in cellular and infection microbiology · 2023
    Article
  5. IgM antibody responses againstFrontiers in cellular and infection microbiology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. KILchip v1.0: A NovelFrontiers in immunology · 2018
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Swapna UplekarCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, United States of America.
Pavitra Nagesh RaoCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, United States of America.
Lalitha RamanathapuramCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, United States of America.
Vikky AwasthiNational Institute of Malaria Research, Indian Council of Medical Research, Sector 8, Dwarka, New Delhi, India.
Kalpana VermaNational Institute of Malaria Research, Indian Council of Medical Research, Sector 8, Dwarka, New Delhi, India.
Patrick SuttonCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, United States of America.
Syed Zeeshan AliNational Institute of Malaria Research Field Unit, Sector 1 Health Center, Raurkela, Odisha, India.
Ankita PatelNational Institute of Malaria Research Field Unit, Civil Hospital, Nadiad, Gujarat, India.
Sri Lakshmi Priya GNational Institute of Malaria Research Field Unit, Indian Council of Medical Research, National Institute of Epidemiology Campus, Ayapakkam, Chennai, Tamil Nadu, India.
Sangamithra RavishankaranNational Institute of Malaria Research Field Unit, Indian Council of Medical Research, National Institute of Epidemiology Campus, Ayapakkam, Chennai, Tamil Nadu, India.
Nisha DesaiNational Institute of Malaria Research Field Unit, Civil Hospital, Nadiad, Gujarat, India.
Nikunj TandelNational Institute of Malaria Research Field Unit, Civil Hospital, Nadiad, Gujarat, India.
Sandhya ChoubeyNational Institute of Malaria Research Field Unit, Sector 1 Health Center, Raurkela, Odisha, India.
Punam BarlaNational Institute of Malaria Research Field Unit, Sector 1 Health Center, Raurkela, Odisha, India.
Deena KanagarajNational Institute of Malaria Research Field Unit, Indian Council of Medical Research, National Institute of Epidemiology Campus, Ayapakkam, Chennai, Tamil Nadu, India.
Alex EapenNational Institute of Malaria Research Field Unit, Indian Council of Medical Research, National Institute of Epidemiology Campus, Ayapakkam, Chennai, Tamil Nadu, India.
Khageswar PradhanNational Institute of Malaria Research Field Unit, Sector 1 Health Center, Raurkela, Odisha, India.
Ranvir SinghNational Institute of Malaria Research Field Unit, Civil Hospital, Nadiad, Gujarat, India.
Aarti JainDepartment of Medicine, Division of Infectious Diseases, University of California Irvine, Irvine, CA, United States of America.
Philip L FelgnerDepartment of Medicine, Division of Infectious Diseases, University of California Irvine, Irvine, CA, United States of America.
D Huw DaviesDepartment of Medicine, Division of Infectious Diseases, University of California Irvine, Irvine, CA, United States of America.
Jane M CarltonCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, United States of America.ORCID 0000-0001-9340-5020
Jyoti DasNational Institute of Malaria Research, Indian Council of Medical Research, Sector 8, Dwarka, New Delhi, India.

Funding

Using Next-Generation Genomics to Study Antimalarial Drug Resistance in IndiaU19AI089676 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARLTON, JANE M · 2010 to 2023
$22.6M
NIAID NIH HHS U19 AI089676
6 · The paper itself

Abstract

Understanding naturally acquired immune responses to Plasmodium in India is key to improving malaria surveillance and diagnostic tools. Here we describe serological profiling of immune responses at three sites in India by probing protein microarrays consisting of 515 Plasmodium vivax and 500 Plasmodium falciparum proteins with 353 plasma samples. A total of 236 malaria-positive (symptomatic and asymptomatic) plasma samples and 117 malaria-negative samples were collected at three field sites in Raurkela, Nadiad, and Chennai. Indian samples showed significant seroreactivity to 265 P. vivax and 373 P. falciparum antigens, but overall seroreactivity to P. vivax antigens was lower compared to P. falciparum antigens. We identified the most immunogenic antigens of both Plasmodium species that were recognized at all three sites in India, as well as P. falciparum antigens that were associated with asymptomatic malaria. This is the first genome-scale analysis of serological responses to the two major species of malaria parasite in India. The range of immune responses characterized in different endemic settings argues for targeted surveillance approaches tailored to the diverse epidemiology of malaria across the world.

Indexed as

Antibody FormationAdolescentAdultAgedAntibodies, ProtozoanAntigens, ProtozoanChildChild, PreschoolCross-Sectional StudiesFemaleHumansIndiaMalaria, FalciparumMalaria, VivaxMaleMiddle AgedAntibodies, ProtozoanAntigens, Protozoan

Identifiers

PMID28118367
PMCPMC5291533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.